Cause still unexplained
When the evaluation does not find an acquired cause or a structural change that explains the crises, genetic testing can help look for the cause.
When the cause of seizures is not clear, exome, genome or other tests can help look for an explanation. A diagnosis can contribute to prognosis, monitoring and, in some cases, therapeutic decisions.
Research seeks answers without reducing the child to a health condition.
When to talk
Epilepsy may have structural, infectious, metabolic, immune, genetic causes or remain unexplained. The indication for the test is individual and considers the type of epilepsy, other signs and the tests already carried out.
When the evaluation does not find an acquired cause or a structural change that explains the crises, genetic testing can help look for the cause.
Crises that begin in the newborn or early childhood period, especially with delay, intellectual disability, autism, regression or other signs, may increase the relevance of genetic evaluation.
Loss of abilities, progressive neurological worsening, or seizures that continue despite adequate treatment require specialized evaluation and may prompt genetic and metabolic testing.
Relatives with epilepsy, similar seizures, intellectual disability, or a known molecular diagnosis can help understand the suspicion.
What a diagnosis can add: help define or refine the cause, inform evolution and follow-up, support therapeutic decisions in specific situations and guide the family. The impact varies depending on the gene, variant and clinical picture; Not every result changes the treatment.
Choice of test
Many different genes may be associated with similar presentations of epilepsy. Broad tests allow you to evaluate multiple hypotheses at once, but a panel or targeted examination may still be appropriate in specific situations.
It mainly evaluates the parts of genes used to produce proteins. The ability to detect losses, duplications, and other types of changes depends on the examination.
Analyzes a larger area of DNA and more types of alterations. More data does not mean a guaranteed answer.
When indicated and possible, analyzing the child and biological parents can facilitate the identification of new variants and the interpretation of inheritance.
Technical limit: DNA repeats, chemical changes in DNA, changes present in only part of the cells, mitochondrial changes, or changes restricted to certain tissues may require specific methods and samples. The report must describe the scope of the examination carried out.
Compare exome and genomeTest day
The test begins with a well-recorded health question and ends with a conversation about the result in the context of the child.
The professional characterizes the episodes, age of onset, development, EEG, images, treatments and family history.
The person responsible receives guidance on what the test analyzes, its limits, possible results and the use of data. The child or adolescent participates in the decision when possible, with an age-appropriate explanation.
The team guides the appropriate sample, and the laboratory correlates the variants to clinical data within the scope of the method. Each family member separately authorizes the use of their sample and data.
The professional explains the report and evaluates upcoming tests, follow-up, evaluation of family members or future review.
Results and limits
Even a molecular diagnosis needs to be related to the type of crisis, EEG, imaging, development and clinical response of the child.
An alteration classified in the report as pathogenic (disease-causing) or probably pathogenic can explain the condition when it matches the signs and what is known about the gene.
Examination may not find a cause. This does not exclude all genetic conditions or invalidate the clinical diagnosis of epilepsy.
A VUS does not confirm the cause and should not prompt medication change, surgery, surveillance, prognosis or predictive testing in family members. If reported in a NeoGenomica examination, it remains accompanied by Infinity VUS.
Immediate service
These guidelines are for first aid. Genetic investigation takes place after stabilization and clinical evaluation.
Move objects away, protect your head with something soft, loosen tight clothing around your neck and stay at your side. Gently turn the person onto their side when it is safe.
Don't hold back the movements. Do not offer objects, food, liquids or medicine yourself. If rescue medication is prescribed, follow the plan you receive exactly.
Call 192 if it is your first crisis, lasts more than five minutes, another crisis starts without complete recovery, there is difficulty breathing, injury or immediate risk.
Observe breathing and remain close until the person regains consciousness. Follow SAMU's guidelines and seek the indicated assessment.
Frequently asked questions
Not necessarily. A crisis can have different causes, and some events that look like crises have another origin. The characterization must be carried out by a health professional; the first crisis also deserves urgent assessment.
No. Epilepsy can have structural, infectious, metabolic, immune, genetic or unknown causes. Furthermore, a genetic cause may arise for the first time in the child and not be inherited.
No. These tests evaluate different aspects. The investigation may include EEG, imaging, laboratory tests, metabolic and genetic evaluation according to clinical evaluation.
In some conditions and for certain mechanisms, a diagnosis can support therapeutic decisions. This does not happen in all cases and any change must be led by the neurologist.
The comparison can show whether a variant was inherited or emerged in the child and help assess its relevance. The strategy depends on the test and the family's availability.
For patients and families
Start with the topic that comes closest to your question.